A quantitative clinical pharmacology-based framework for model-informed vaccine development
Historically, vaccine development and dose optimization have followed mostly empirical approaches without clinical pharmacology and…
Jim Gallagher2023年11月20日
Key Lessons from the 2nd Annual FDA ASCO WORKSHOP on Getting the Dosage Right: Optimizing Dosage Selection Strategies in Combination Cancer Therapies
Cancer treatment has evolved from generally cytotoxic therapies towards drugs that target specific pathways and…
Certara2023年11月17日
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost
Quantitative systems pharmacology (QSP) models generate predictions by formalizing biological understanding and integrating multiscale data,…
Jim Gallagher2023年11月16日
The “Animal Rule” – What if a clinical trial simply isn’t ethical?
Clinical trials always pose a challenge to demonstrating a drug’s safety and efficacy. Sometimes, the…
Certara2023年11月10日
Certara Reports Third Quarter 2023 Financial Results
Reiterates Full Year 2023 Financial Guidance PRINCETON, N.J.— November 8, 2023-- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a…
Danielle Pillsbury2023年11月8日
Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval?
今日、臨床薬理情報は医薬品添付文書の50％以上を占めています。Inadequate clinical pharmacology development…
Danielle Pillsbury2023年11月7日
Strategy to overcome clinical pharmacology challenges for regulatory approvals [APAC Webinar]
今日、臨床薬理情報は医薬品添付文書の50％以上を占めています。Inadequate clinical pharmacology development…
Danielle Pillsbury2023年11月6日
Certara Recognized as 2023 Employer of Choice
PRINCETON, N.J.— November 1 2023, Certara (Nasdaq: CERT), a global leader in biosimulation, today announced…
Certara2023年11月1日
Can’t ChatGPT Do That? Practical Applications for AI in Drug Discovery & Development
Explore how Certara.AI tackles the limits of generalized GPTs like ChatGPT to transform drug discovery,…
Certara2023年10月31日
